Key facts
- Notable investors include Polar Apex.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Lexitell Life Sciences
- ·The full record, as it builds
Funding rounds
No funding rounds for Lexitell Life Sciences are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lexitell Life Sciences
Developer of artificial intelligence executive support technology designed to assist senior life sciences executives with decision-making and operational tasks. The company's platform provides a private artificial intelligence-based Chief of Staff that analyzes context, supports information synthesis, and assists with executive communications and task workflows, enabling life sciences executives to manage complex strategic and operational activities with greater clarity and efficiency.
- Sector
- Information Technology
- HQ
- Denver, CO, United States
- Founded
- 2025
- Employees
- 2
- Website
- lexitell.com/
- Ownership
- Privately Held (backing)
Lexitell Life Sciences doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lexitell Life Sciences shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lexitell Life Sciences in its N-PORT filings yet. We sweep new filings monthly.